Express Scripts Pushing Manufacturers To Lower List Prices By Offering Cheaper Brand Alternatives

Companies should introduce same drug under new NDC at lower list price to overcome difficulties of reducing list prices on existing brands, PBM says.

Express Scripts HQ

Pharmacy benefit manager Express Scripts Holding Co. is talking with manufacturers about effectively lowering drug prices by introducing an identical product at a cheaper list price as an alternative to just reducing the list price of a brand already on the market.

The approach would be less disruptive to existing drug purchasing contracts with the supply chain and insurance plan financials and would also offer a way for patients to immediately access...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access